The intestinal epithelium not only acts as the physical structure that separates the intestinal lumen from the body but also actively participates in intestinal barrier functions. In the past decade, significant progress has been made in the development of culture technologies to maintain intestinal epithelial cells ( 
Introduction
The intestinal epithelium is composed of a monolayer of simple columnar epithelial cells and folded to generate crypt and villus architecture. It comprises differentiated cells of multiple lineages-absorptive enterocytes, goblet cells, enteroendocrine cells, Paneth cells, tuft cells and M cells-all of which originate from intestinal stem cells (ISCs). As tight junctions connect adjacent epithelial cells and seal the intercellular spaces, the epithelium separates the intestinal lumen from the underlying tissues (1).
The epithelium not only acts as a static barrier but also serves as an active participant in dynamic processes of intestinal barrier functions. Goblet cells and Paneth cells secrete protective mucins and anti-microbial peptides, respectively, and contribute to the first line of defense against pathogenic microorganisms (2) . Tuft cells initiate immune responses, particularly against parasitic infections in the intestine (3) . The intestinal M cells, a subset of intestinal epithelial cells (IECs) covering gut-associated lymphoid tissue (GALT) lymphoid follicles, are specialized to take up intestinal luminal antigens to regulate mucosal immune responses (4) . Furthermore, the intestinal epithelium is known to communicate with various types of non-epithelial cells, for example through cytokine production or direct antigen presentation, and control inflammatory and immune responses (2) . It is thus apparent that the intestinal epithelium is an integral component of the protective barrier between the intestinal luminal environment and internal milieu of our bodies.
In the last decade, there has been significant progress in the development of culture technologies to maintain IECs in vitro. The IECs grown in those novel culture systems recapitulate the physiology, the three-dimensional (3D) architecture and the genetic signature of the original intestinal epithelium and thus are called intestinal organoids (5, 6) . Studies have shown that at least three sources of cells-isolated IECs (7) (8) (9) (10) (11) (12) (13) (14) , IECs generated in vitro through methods such as direct lineage reprogramming of fibroblasts (15) or cells that develop from directed differentiation of pluripotent stem cells (PSCs) (16)-can be grown as epithelium-only organoids or as epithelium plus non-epithelial (stromal and mesenchymal) organoids. Given that the organoids can reconstitute intestinal epithelial tissues when placed back into animals, organoid technologies are expected to accelerate regenerative medicine for human intestinal diseases (17) . In addition, transplantation experiments have clearly shown that the cells cultured in organoids retain many physiological features including their tissue regeneration capabilities, which further provides a rationale to use organoids as a model system to study the intestinal epithelium in vitro.
In this article, I first summarize advances in the development of intestinal organoid technology. Then, I describe recent work that utilizes organoids to study intestinal barrier functions, describing the protective functions of particular epithelial cell types and also the interactions of IECs with microorganisms or immune cells.
Intestinal organoids
The intestinal epithelium forms crypt-villus structures in the small intestine and crypt structures in the colon, respectively. It has long been accepted that ISCs, capable of self-renewal and multi-lineage differentiation, reside at crypt bottoms (18) (19) (20) . Studies have shown that several signaling pathwayssuch as Wnt, Notch, epidermal growth factor (EGF) and bone morphogenetic protein pathways-positively and negatively regulate homeostasis of ISCs at the crypt base (20) .
In 2007, Barker et al. identified a gene encoding leucinerich repeat-containing receptor 5 (Lgr5), a member of the G-protein-coupled receptor family, as the molecular marker of ISCs (21) . They demonstrated that Lgr5, a target gene of the activated Wnt signal in IECs, labels the cells at the crypt base of the small intestine and colon. They further showed, by genetic lineage tracing, that Lgr5 + cells represent functional ISCs (21) . Several other genes have been subsequently suggested as markers of ISCs that are distinct from Lgr5 + cells regarding their localization (22) (23) (24) . In this article, I do not discuss the hierarchical relationships of these different putative stem cell populations; however, recent evidence has shown that, when Lgr5 + stem cells are lost through damage, several populations of differentiated cell types revert to multipotent stem cells and initiate crypt regeneration (20) .
In 2009, two research groups independently developed innovative new methods of culturing normal, untransformed IECs containing Lgr5 + ISC populations in vitro. Sato et al. described that, when crypt cells of the mouse small intestinal epithelium are embedded in Matrigel, they grow for an extended period in the presence of EGF, noggin and Rspo1 in the culture medium (7) . Under these conditions, small intestinal cells self-organize into epithelium-only 3D structures composed of central spherical parts and numerous structures protruding outward. The outer regions resemble the crypts of the small intestine, with Lgr5 + ISCs and Paneth cells residing at their apex, whereas the central sphere consists mostly of differentiated cells (Fig. 1A) . Another study by Ootani et al. developed an air-liquid interface model to culture mouse intestinal spheres. They cultured minced fragments obtained from the entire intestinal wall, rather than the isolated epithelium, in a 3D gel made from type 1 collagen (14) . This model is a composite system that contains both epithelial and nonepithelial elements of the intestine, where non-epithelial cells serve a role in supporting self-renewal and multi-lineage differentiation of Lgr5 + ISCs (Fig. 1A) . Although there have been various nomenclatures for these different 3D structures, the term 'organoid' is widely accepted to describe a structure consisting of organ-specific cell types that self-organizes tissue-like structures in vitro (5, 6, 25) . Therefore, I use 'organoid' in this article to describe both types of 3D cell cultures, irrespective of whether they consist of pure epithelial populations or contain non-epithelial elements. I also use 'epithelial organoids' in cases where I need to specify 'organoids' as 'epithelium-only organoids'.
Following these seminal papers, various types of organotypic culture methodologies were developed for other intestinal cells, such as colonic cells and fetal intestinal progenitor cells of mouse and other species including humans (9) (10) (11) (12) (13) (14) . In addition, Spence et al. developed a method to generate intestinal tissues by inducing directed differentiation of human PSCs (hPSCs), such as embryonic stem cells and induced PSCs (iPSCs), into spheroids composed of both epithelial and mesenchymal cell types, with the epithelial lining allocated to the luminal surface and the stratified mesenchyme to the outer parts (16) . These multi-layered structures, termed human intestinal organoids (HIOs), contain cells derived from different germ layers and recapitulate the complex tissue architecture of the intestine (Fig. 1A) .
A recent study by Miura and Suzuki has further shown that transcription-factor-mediated direct lineage reprogramming of fibroblasts allows for the generation of intestinal progenitor cells, which can form epithelial organoids (Fig. 1A) (15) . This finding means that intestinal organoid cultures can now come from various sources. For details of the technical aspects of these different types of organoid systems, readers can refer to several excellent review articles (26) (27) (28) (29) .
Tissue regeneration capabilities of ISCs in intestinal organoids
Intestinal organoids have immense potential for therapeutic use in human intestinal diseases. Our group first described that mouse colonic epithelial organoids can regenerate colonic epithelia when transplanted back into the host animal (11) . In this study, acute colitis was induced in recipient mice to generate ulcerations in the colon, and the cultured colon epithelial organoids, labeled by enhanced green fluorescent protein (EGFP), were infused in recipient mice through an enema. The transplanted cells adhered to the injured recipient tissue and, by 4 weeks, they reconstituted a healthy colonic epithelium that contained proliferating cells and all terminally differentiated cell types. Notably, the engrafted crypts were entirely EGFP+ at this point, suggesting that each crypt formed a clonal population derived from EGFP+ stem cells. When tetramethylrhodamine isothiocyanate (TRITC)-conjugated dextran (TRITC-dextran) was administered orally, blood TRITC concentrations in transplanted mice were comparable to those in control mice, indicating the maintenance of epithelial barrier function in graft tissues (11) . Furthermore, colonic epithelial organoids, whose culture was initiated from a single Lgr5 + colonic stem cell, engrafted in multiple recipients as normal colonic epithelia (11) . This study thus provides proof of principle that damaged intestinal epithelia can be repaired by transplanting IECs that are isolated and then expanded as organoids in vitro. Studies have now shown that various types of intestinal epithelial organoids, such as those derived from fetal mouse small intestines (12) , adult mouse small intestines (30, 31) , adult human colons (32) or even those generated from mouse fibroblasts by direct lineage reprogramming (15, 33) , can all regenerate the intestinal epithelium in vivo. Intriguingly, Fukuda et al. demonstrated that small intestinal epithelial organoids of adult mouse origin regenerate new epithelia that morphologically and functionally preserve mature small intestinal phenotypes even after heterotopic engraftment into the recipient colon (30) . This study indicated that there exists an epithelium-intrinsic program that allows adult tissue-derived organoids to preserve their segment-specific characteristics throughout isolation, organoid culture and grafting processes.
The tissue regeneration capabilities of HIOs produced by directed differentiation of hPSCs have also been demonstrated by their transplantation under the kidney capsule of immunocompromised mice (34) . Furthermore, the following studies have demonstrated that HIOs also develop into adult human intestine-like tissues when they are seeded onto a synthetic tubular scaffold and then implanted into the mouse abdomen (35) or directly injected at the site of mechanically induced mucosal wounds in the mouse colon (36) . Interestingly, a recent study described a method to add components of the enteric nervous system (ENS) into HIOs by combining hPSC-derived neural crest cells (37) . Such efforts to incorporate multiple elements of the tissue and increase the complexity of intestinal organoids hold significant promise to generate tissue-engineered intestines that contain the ENS, which controls intestinal motility.
There are numerous points to be experimentally addressed before regenerative medicine becomes a clinical reality, potentially including the replacement of all factors in the culture medium with GMP grade reagents and the development of protocols to assess the risk of tumorigenicity in human organoids. However, steady progress in this research field will enable us to envisage future situations where various types of intestinal organoids are used as the source for regenerative medicine to repair injured intestines or to compensate for the loss of intestinal functions in human intestinal diseases (Fig. 1B) .
Organoids to study protective functions of IECs
In addition to uses within regenerative medicine, intestinal organoids have advantages over human carcinoma-derived cell lines used previously for modeling a variety of barrier functions exerted by IECs in vitro. One important feature of intestinal organoids is that they include all types of terminally differentiated IECs including absorptive enterocytes, goblet cells, enteroendocrine cells, Paneth cells, tuft cells and M cells. Together with their highly expandable nature, organoids are ideal for studying functions of these specialized cell types (Fig. 1B) .
Goblet cells are a secretory epithelial cell type present in both the small intestine and the colon. The principal function of goblet cells is the production of Muc2 mucin, a heavily O-glycosylated glycoprotein, which forms a protective mucus layer over the inner surface of the epithelium (38, 39) . Organoid technology has now served as a powerful tool to elucidate the link between goblet cell dysfunction and the pathology of human diseases. Cystic fibrosis (CF) is an inherited disorder caused by defective expression and function of the CF transmembrane conductance regulator (CFTR), an epithelial anion channel responsible for secretion of chloride and bicarbonate (40) (41) (42) . Interestingly, wildtype organoids and organoids derived from CF patients were shown to behave differently when stimulated with forskolin, which activates CFTR by raising the amount of intracellular cyclic AMP, recapitulating the functional defect of CFTR in CF patients (43) . Although the disease is marked by mucus hyperproduction and plugging in organs including the intestine, the involvement of goblet cells in the pathophysiology of CF remained unclear. But, by using small intestinal epithelial organoids, Liu et al. clearly showed that goblet cells in Cftr-knockout organoids exhibited various changes that led to alterations in exocytotic dynamics of mucus secretion (44) .
Paneth cells are secretory epithelial cells that reside at the crypt base of the small intestine, where they have various physiological functions such as production of anti-microbial peptides (45) (46) . Instead, by using epithelial organoids, they showed that Paneth cell degranulation is primarily controlled by IFN-γ-a pro-inflammatory cytokine produced by immune cells.
Studies have also explored the linkage between Paneth cell functions and autophagy, an intracellular mechanism through which a portion of cytoplasm is delivered to lysosomes to be degraded (47) . Two recent studies showed, using organoidbased assays, that ATG16L1 and Atg5-both of which are known to be involved in the autophagy process-have protective functions in Paneth cells to inhibit TNFα-mediated cell death (48, 49) . As dysregulation of autophagy in the intestinal epithelium has been implicated in human inflammatory bowel disease (IBD) (50), further study on Paneth cell function and its molecular basis would be helpful to understand the pathogenesis of IBD.
Tuft cells are recognized by their long and thick microvilli on their apical surface and also a well-developed cytoplasmic tubulovesicular system (3), but their function remained unclear until recently. Three independent studies have recently elucidated the pivotal function of tuft cells related to anti-helminth immunity in the intestine. These studies revealed that, following infection with helminths, intestinal tuft cells initiate mucosal type 2 responses through IL-25 secretion, which in turn promotes expansion of IL-13-producing group 2 innate lymphoid cells (ILC2s) to accelerate worm expulsion (51) (52) (53) . These studies also revealed the presence of a positive feedback loop in the epithelial-ILC2 response circuit by using intestinal organoid systems, demonstrating that ex vivo stimulation of intestinal epithelial organoids with IL-13, but not IL-25, increased tuft cell abundance (51) (52) (53) .
M cells are highly specialized IECs located in the follicleassociated epithelium covering the lymphoid follicles of the GALT. They play a central role in transporting antigens and microorganisms to the underlying lymphoid tissue to regulate mucosal immune responses. Although the mechanisms of the development of M cells have long remained undetermined, studies have suggested that M cells originate from Lgr5 + ISCs, involving receptor activator of NF-κB (RANK) ligand (RANKL) signaling and the Ets family transcription factor Spi-B (54-56). Kanaya et al. further extended this research by incorporating the organoid system and showed that NF-κB activation evoked by the RANK-tumor necrosis factor receptor-associated factor 6 (TRAF6)-NF-κB axis is essential for the development of M cells (57) . The use of intestinal epithelial organoids for this study confirmed the epithelium-intrinsic factors for this M cell differentiation.
The studies described above are only examples of how intestinal organoids are employed for research on the functions of particular IECs and their mechanistic bases. Unlike cancer-derived cell lines, intestinal organoids recreate the physiological cellular composition in vitro and are thought to recapitulate the development and maturation processes occurring in the intestinal epithelium in vivo. In addition, the simple and expandable nature of organoids enables real-time imaging of cellular behaviors and also biochemical analyses of IEC populations.
Of note, the combined use of single-cell RNA sequencing technology and the intestinal organoid system are becoming efficient approaches both for studying major epithelial cell types and detecting rare populations of IECs. Grün et al. showed that, by analyzing the RNA expression profiles of a large number of randomly selected cells from mouse intestinal organoids, the Reg4 gene can serve as a novel marker for a rare population of hormone-producing intestinal cells (58) . They also identified a minor population of secretory cells as a subset of cells expressing the stem cell marker gene, Lgr5 (58) . Another study by Haber et al. showed that ex vivo expansion of IECs in epithelial organoids allowed for the characterization of a molecular signature of M cells by single-cell RNA sequencing, which were unsuccessful in initial survey using cells isolated from intestinal tissues due to their scarcity (59) . These studies demonstrate that a survey of gene expression profiles of individual IECs at single cell levels will become an efficient approach to identify previously unknown, rare populations of IECs and their molecular characteristics.
Intestinal organoids to model host-microbe interactions
Intestinal organoids are now also facilitating significant advancements in the area of host-microbe interactions, providing model systems to investigate how microorganisms physically interact with and invade the intestinal epithelium (Fig. 1B) .
Several studies have examined the pathogenesis of Salmonella infection using intestinal organoids. Zhang et al. reported that in vitro incubation with murine colonic epithelial organoids allowed the invasion of Salmonella into IECs. They found this model useful to investigate the changes in IECs regarding morphology, gene expression patterns and function of epithelial tight junctions following Salmonella infection (60). Wilson et al. developed a system of Salmonella infection by using microinjection to approach the inner surface of murine small intestinal epithelial organoids. They showed that bacterial growth was significantly reduced in organoids through a mechanism involving α-defensins secreted into the lumen (61) . The utility of hPSC-derived HIOs for the study of Salmonella infection has also been shown: Forbester et al. performed microinjection of Salmonella into the luminal space in HIOs and showed significant changes in transcriptional profiles in IECs, proposing that the model could also become a valuable tool for the study of Salmonella infection in humans (62) .
Clostridium difficile, an enteric pathogen that causes antibiotic-associated diarrhea in humans, has also been a subject of research using intestinal organoids. By using hPSC-derived HIOs, Leslie et al. showed that this spore-forming anaerobe can persist in the organoid lumen and affect epithelial barrier function (63) . Engevik et al. also utilized hPSC-derived HIOs and showed that microinjection of C. difficile decreased the expression of the Na + /H + exchanger NHE3, which may alter the microbiota composition in the intestine (64) . The same researchers also suggested the involvement of changes in intestinal mucus in the pathogenesis of C. difficile infection, as they found that injection of C. difficile into HIOs resulted in reduced production of MUC2 mucin (64) . These studies have shown that microinjection of HIOs serves as a model to understand the pathogenesis of C. difficile.
The pathogenesis of other bacterial infections has also been studied in intestinal organoid systems. Karve et al. demonstrated that while hPSC-derived HIOs were not damaged by infection with commensal Escherichia coli, infection with E. coli that produce Shiga toxin resulted in the loss of epithelial integrity (65) . Another study, by Rajan et al., utilized epithelial organoids derived from different segments of the human small and large intestines, and showed that there exist segment-specific tropisms in physical contact between IECs and enteroaggregative E. coli, a diarrheal pathogen of both acute and chronic diarrhea (66) .
A recent study also described the utility of intestinal epithelial organoids as a model system to investigate infection by Cryptosporidium, a protozoan parasite (67) . The researchers showed that Cryptosporidium can infect and propagate within human intestinal epithelial organoids, completing its complex life cycle. They also showed by gene expression analyses that genes involved in innate immune responses are activated in response to Cryptosporidium infection. Furthermore, the study demonstrated that absorptive enterocytes are the cell type targeted by Cryptosporidium in the small intestinal epithelium (67) .
Intestinal organoids have also been used to study the pathogenesis of several enteric viruses. Rotavirus is a double-stranded RNA virus that can cause severe gastroenteritis in children. Several studies have demonstrated that both intestinal epithelial organoids (68) and HIOs (69) allow infection by human rotavirus in IECs. Importantly, all these studies showed high levels of viral replication in intestinal organoids, reaching, for example, a level ten times greater than that seen in conventionally used cell lines (70) . Moreover, it was shown that rotavirus replication in epithelial organoids is efficiently restricted by type I interferons (68, 69) , indicating that organoid models can be used for evaluation of the efficacy of rotavirus medications.
Enterovirus is a term given for a group of single-stranded RNA viruses such as Coxsackieviruses A, Coxsackieviruses B, polioviruses, echoviruses and other enteroviruses. Its infections are highly prevalent worldwide. Drummond et al. found that human intestinal epithelial organoids were susceptible to infection by multiple human enteroviruses to varying degrees (71) . Interestingly, enteroviruses induced potent antiviral signaling pathways in response to infection in organoid cells, whereas they did not in cancer-derived cell lines such as Caco-2 cells, indicating that intestinal organoids can be
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used as platforms to define the complex interaction that exists between enteroviruses and the intestinal epithelium (71) .
Human norovirus is a single-stranded RNA virus that causes frequent outbreaks of gastroenteritis worldwide. Despite its prevalence and clinical importance, the investigation of this virus species has been hampered by the lack of a robust in vitro culture system. Ettayebi et al. demonstrated for the first time that replication of multiple human norovirus strains can be achieved when human intestinal epithelial organoids are used as the host (72) . In addition, they showed an exciting finding that some human norovirus strains required bile, a factor present in the intestinal milieu, for their efficient replication. Following this seminal paper, it was reported that hPSCderived HIOs could also become a model to study human norovirus infection (73) . Future studies using organoid models will provide novel insights that could significantly reduce the global burden of norovirus.
It is important to note that, although the injection of microbes into 3D organoids enables researchers to assess physiological responses in IECs, it remains challenging to apply the synchronous manipulation to a large number of organoids. To overcome such shortcomings of 3D organoid systems, several researchers have begun devising novel methods of two-dimensional (2D) IEC culture, which allows for the largescale analysis of the interaction between microbes and the apical surface of IECs (Fig. 1A and B) . For example, Moon et al. developed a method for the culture of primary mouse IEC monolayers and showed that the system allowed them to investigate the process of immunoglobulin A transcytosis across the epithelium (74) . Similar efforts have been made to culture 2D monolayers of various types of intestinal cells, such as the mouse small intestine (75, 76) , mouse colon (75, 77) , porcine small intestine (78), human small intestine (75, 79) , human colon (75, 77, 79, 80) and iPSC-derived HIOs (81) . Indeed, such 2D culture systems have been demonstrated as novel experimental platforms for modeling host-microbe interactions. The first indication of effective norovirus replication in IECs, which is described earlier in this section, employed a method to culture human intestinal epithelial organoid cells as 2D monolayers in culture plates or Transwells (72) . Another example is the work by In et al., which successfully assessed the initial molecular events in the interaction between enterohemorrhagic E. coli and the colonic epithelium cultured as a monolayer on Transwell filters (82) . These studies thus suggest that investigations on the interactions between IECs with other microorganisms are also feasible with 2D IEC monolayer cultures adapted from organoids. This approach may allow for controlled access to the apical surface of IEC with easy handling, thus facilitating reproducible analyses of host-microbe interactions.
Organoids to investigate cross-talk between IECs and immune cells
In addition to acting as a protective barrier against luminal pathogens, the intestinal epithelium senses changes in luminal factors and then controls epithelial-immune cell communications. Both innate and acquired immune cell populations (e.g. ILCs, mast cells, dendritic cells, macrophages, T cells and B cells) bidirectionally communicate with IECs (2).
Intestinal organoids have now been exploited as a system to study such cross-talk between the epithelium and various immune cells, which is essential for the maintenance of immunological homeostasis in the intestine (Fig. 1B) .
When the process of infection or inflammation begins, circulating blood-derived monocytes infiltrate the intestinal mucosa and differentiate into responsive macrophages (83) . It is thus critical to interrogate the molecular interplay between macrophages and IECs to understand the mechanisms of mucosal immune regulation.
Noel et al. developed a unique in vitro co-culture system consisting of human monocyte-derived macrophages and IECs (84) . They first expanded human IECs as epithelial organoids and then seeded fragments of those IECs onto a Transwell membrane insert that was pre-coated with type IV collagen. After verification of the 2D IEC monolayer formation, monocyte-derived macrophages were applied from the bottom surface of the membrane inserts, allowing them to be in close contact with the basolateral side of the 2D IEC monolayer, being separated only by a permeable membrane (84) . They showed that both IECs and macrophages stayed viable and functionally active, changing their morphology and cytokine production patterns in this combined culture setting. They further demonstrated that, when the apical side of IECs in this co-culture system was exposed to bacterial pathogens, the macrophages attached underneath could sense the luminal bacteria, changing themselves morphologically and extending cell membrane projections across the IEC monolayer (84) . It is thus indicated that the co-culture system they developed may serve as a unique system to study the mechanisms of phagocytic activity and also the following processing of luminal antigens in intestinal macrophages.
Intestinal intra-epithelial lymphocytes (IELs) also play important roles in local immune response. IELs are known as heterogeneous T-cell populations classified into conventional IELs, which develop through thymic selection and migrate into the intestine, and unconventional IELs, which contain unique T-cell subsets that recognize self-antigens and nonpeptide antigens (85) . Although both types of IELs serve important roles in local immune response, studies of IELs in each subset had been significantly hampered by a lack of suitable culture methods.
My research team has hypothesized that intestinal organoids that preserve many physiological properties of intestinal epithelia would provide a more suitable microenvironment for the sustained culture of IELs and become a novel platform to achieve efficient co-culture systems for IELs. We demonstrated that purified IELs and epithelial organoids, independently isolated from mouse intestines and embedded in a 3D extracellular matrix, can be maintained together in a culture medium containing a cytokine mix of IL-2, IL-7 and IL-15 (86) . In this setting, both conventional and unconventional IELs showed significant proliferation and incorporation into the epithelial organoid. This finding suggests that some unidentified signals, provided by direct cell-cell contact with IECs or secreted factors from IECs, sufficiently support the survival and expansion of both types of IELs.
By using this novel co-culture system, we further analyzed the temporal and spatial interaction between IELs and intestinal epithelial organoids. Time-lapse imaging showed that IELs are highly motile; they migrate toward the organoid, come in direct contact with it, stay temporarily and then egress. In addition, we observed that IELs continually and extensively change their morphology, occasionally interposing their cytoplasmic projections between two adjacent IECs (86) . A recent study by Hu et al. employed the co-culture system and revealed that such motility of γδ T IELs, a major subset of unconventional IELs, is controlled by IL-15 (87) . These studies thus suggest that the organoid-based in vitro co-culture system could become a useful system to investigate the interaction between IECs and IELs.
Conclusions
In this article, I have showcased recent studies that utilized intestinal organoids to study intestinal epithelial barrier functions. As intestinal organoids restore physiological cellular composition, they represent suitable models to study the mechanism of development and differentiation or the molecular basis of functions in specific types of IECs, such as goblet cells, Paneth cells, tuft cells and M cells. Various forms of intestinal organoids can also serve as model systems for evaluating the dynamic processes occurring at the hostmicrobe interface. Furthermore, intestinal organoids, particularly the intestinal epithelial organoids that lack non-epithelial components, provide a reductionist approach to understand the complexity of intestinal immune homeostasis through coculture with various types of immune cells. 
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